ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
97 569,95
-0,19%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Neurocrine Biosciences Inc (0K6R) Cours

Neurocrine Biosciences Inc

Neurocrine Biosciences Inc (0K6R)

LSE
91,67
0,00
(0,00%)
Fermé 21 Décembre 5:30PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
91,67
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
31
0,00 Fourchette du Jour 0,00
91,67 Plage de 52 semaines 91,67
Cap du marché
9,007B
Clôture Veille
91,67
Ouverture
-
Dernière Transaction
1
@
135.33
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
943
Actions en circulation
98 252 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
53,29
Bénéfice par action (BPA)
2,54
Chiffre d'affairess
1,89B
Bénéfice net
249,7M

À propos de Neurocrine Biosciences Inc

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.neurocrine.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Neurocrine Biosciences Inc est coté dans le secteur Biological Pds,ex Diagnstics de la London Stock Exchange avec le ticker 0K6R. Le dernier cours de clôture d'Neurocrine Biosciences était de US$91,67. Au cours de la dernière année, les actions de Neurocrine Biosciences ont été négociées dans une fourchette de prix de US$ 91,67 à US$ 91,67.

Neurocrine Biosciences compte actuellement 98 252 000 actions en circulation. La capitalisation boursière d'Neurocrine Biosciences est de US$9,01 milliard. Neurocrine Biosciences a un ratio cours/bénéfice (ratio PE) de 53.29.

0K6R Dernières nouvelles

Plus de nouvelles

Diurnal Group PLC EXERCISE OF OPTIONS

Diurnal Group PLC 28 October 2022 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT...

28 Octobre 2022
UK Regulatory

Diurnal Group PLC COURT SANCTION OF SCHEME OF ARRANGEMENT

Diurnal Group PLC 28 October 2022 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT...

28 Octobre 2022
UK Regulatory

Diurnal Group PLC Form 8.3 - IPG - Diurnal Group PLC

Diurnal Group PLC 08 September 2022 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the...

08 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 08 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

08 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 07 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

07 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 06 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

06 Septembre 2022
UK Regulatory

Diurnal Group PLC Form 8 (OPD) (Diurnal Group)

Diurnal Group PLC 05 September 2022 FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code") 1. KEY INFORMATION (a...

05 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 05 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

05 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 02 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

02 Septembre 2022
UK Regulatory

Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Diurnal Group plc

Stifel Nicolaus Europe Limited 01 September 2022 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

01 Septembre 2022
UK Regulatory
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10091.6791.6791.6786091.67DE
40091.6791.6791.6792891.67DE
120091.6791.6791.6794391.67DE
260091.6791.6791.6766791.67DE
520091.6791.6791.6769191.67DE
1560091.6791.6791.67124991.67DE
2600091.6791.6791.6790791.67DE

0K6R - Frequently Asked Questions (FAQ)

What is the current Neurocrine Biosciences share price?
The current share price of Neurocrine Biosciences is US$ 91,67
How many Neurocrine Biosciences shares are in issue?
Neurocrine Biosciences has 98 252 000 shares in issue
What is the market cap of Neurocrine Biosciences?
The market capitalisation of Neurocrine Biosciences is USD 9,01B
What is the 1 year trading range for Neurocrine Biosciences share price?
Neurocrine Biosciences has traded in the range of US$ 91,67 to US$ 91,67 during the past year
What is the PE ratio of Neurocrine Biosciences?
The price to earnings ratio of Neurocrine Biosciences is 53,29
What is the cash to sales ratio of Neurocrine Biosciences?
The cash to sales ratio of Neurocrine Biosciences is 7,05
What is the reporting currency for Neurocrine Biosciences?
Neurocrine Biosciences reports financial results in USD
What is the latest annual turnover for Neurocrine Biosciences?
The latest annual turnover of Neurocrine Biosciences is USD 1,89B
What is the latest annual profit for Neurocrine Biosciences?
The latest annual profit of Neurocrine Biosciences is USD 249,7M
What is the registered address of Neurocrine Biosciences?
The registered address for Neurocrine Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Neurocrine Biosciences website address?
The website address for Neurocrine Biosciences is www.neurocrine.com
Which industry sector does Neurocrine Biosciences operate in?
Neurocrine Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TIRTiger Royalties And Investments Plc
0,15p
(50,00%)
3,41M
BAYBay Capital Plc
5,50p
(19,57%)
209,68k
MASTMast Energy Developments Plc
0,19p
(18,75%)
20,09M
MHNMenhaden Resource Efficiency Plc
148,50p
(18,33%)
1M
ZENZenith Energy Ltd.
2,50p
(16,28%)
3,93M
TRYBTribe Technology Plc
0,115p
(-79,09%)
24,27M
NMTNeometals Ltd
2,75p
(-35,29%)
49,4k
SNGSynairgen Plc
2,46p
(-34,31%)
4,31M
TM1Technology Minerals Plc
0,185p
(-26,00%)
174,03M
AYMAnglesey Mining Plc
0,70p
(-17,65%)
2,99M
NTVONativo Resources Plc
0,002p
(5,26%)
971,94M
TRPTower Resources Plc
0,035p
(9,38%)
620,03M
LLOYLloyds Banking Group Plc
54,16p
(-0,26%)
341,48M
ORCPOracle Power Plc
0,0255p
(-1,92%)
192,93M
TM1Technology Minerals Plc
0,185p
(-26,00%)
174,03M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
0K6R
Neurocrine Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés